Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetic nephropathy. Future avenue.

G C Viberti1, J Yip-Messent, A Morocutti

  • 1Unit for Metabolic Medicine, United Medical School, Guy's Hospital, London, United Kingdom.

Diabetes Care
|September 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiple myeloma and paget disease with abnormal skull lesions and intracranial hypertension.

Mediterranean journal of hematology and infectious diseases·2012
Same author

Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study.

Diabetologia·2009
Same author

Genetic association analyses of non-synonymous single nucleotide polymorphisms in diabetic nephropathy.

Diabetologia·2008
Same author

Misleading meta-analysis: a need to look beyond the headlines.

Diabetic medicine : a journal of the British Diabetic Association·2007
Same author

Comment on: Boden et al. (2007) Combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: prevention of fluid retention: Diabetes 56:248-255.

Diabetes·2007
Same author

Combined analysis of three crossover clinical pharmacology studies of effects of rabeprazole and esomeprazole on 24-h intragastric pH in healthy volunteers.

Alimentary pharmacology & therapeutics·2007

Identifying at-risk diabetic patients early is key to preventing diabetic kidney disease. Early detection of risk factors like hypertension and dyslipidemia can help prevent progression to kidney complications.

Area of Science:

  • Nephrology
  • Endocrinology
  • Cardiovascular Medicine

Background:

  • Diabetes mellitus is the primary cause of end-stage renal failure (ESRF) in the US, leading to significant cardiovascular morbidity and mortality.
  • Diabetic nephropathy affects only 40% of diabetic patients, suggesting potential for primary prevention in at-risk individuals.
  • Early risk factors for diabetic kidney disease include hypertension, family history of diabetic nephropathy, and cardiovascular disease (CVD).

Purpose of the Study:

  • To identify early risk indicators for diabetic renal disease and cardiovascular disease (CVD) in patients with diabetes mellitus.
  • To explore the possibility of primary prevention strategies targeting at-risk diabetic patients.
  • To prevent the progression from normoalbuminuria to microalbuminuria in individuals at high risk.

Related Experiment Videos

Main Methods:

  • Review of existing literature associating risk factors with diabetic renal complications.
  • Identification of early risk indicators present at the normoalbuminuria stage.
  • Analysis of the impact of interventions on disease progression.

Main Results:

  • Predisposition to hypertension, family history of diabetic nephropathy, and family history of CVD are independently associated with diabetic renal complications in insulin-dependent diabetes mellitus (IDDM).
  • Risk factors for macrovascular damage (hypertension, dyslipidemia, insulin resistance) are detectable early, even at the normoalbuminuria stage.
  • While treatments can delay ESRF and slow proteinuria, no study has demonstrated primary prevention of diabetic renal disease.

Conclusions:

  • Early identification of individuals at risk for diabetic renal disease and CVD is crucial.
  • Focusing on preventing the transition from normoalbuminuria to microalbuminuria in high-risk patients is a critical goal.
  • Primary prevention strategies are needed to halt the progression of diabetic kidney disease.